Ledger.Open graph →
SEC Form D · filed April 22, 2022

Invea Therapeutics, Inc

Offering
$5.8M
Sold
$1.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
GUILFORD, CT
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Salvatore Alesci · Guilford, CTExecShunichiro "Steve" Okada · Guilford, CTExecAman Kant · Guilford, CTExecSandeep Laumas · Raleigh, NCDirectorDemetrios Kydonieus · Guilford, CTDirectorMichael Aiello · Guilford, CTExecKrishnan Nandabalan · Guilford, CTExec · Director · PromoterKerrie Brady · Guilford, CTDirectorJonathan Zalevsky · NORFOLK, VADirectorVimal Mehta · Guilford, CTDirectorSalvatore Alesci · Guilford, CTExecJonathan Zalevsky · NORFOLK, VADirectorShunichiro "Steve" Okada · Guilford, CTExecAman Kant · Guilford, CTExecSandeep Laumas · Raleigh, NCDirectorDemetrios Kydonieus · Guilford, CTDirectorVimal Mehta · Guilford, CTDirectorMichael Aiello · Guilford, CTExecKrishnan Nandabalan · Guilford, CTExec · Director · PromoterKerrie Brady · Guilford, CTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗